Tyrosine kinase inhibitors have become a revolutionary approach and drastically changed the landscape of treatment approaches in treating non small cell lung cancer. It enormously improved the quality

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs) is a group of medicine that plays an important role in treating non-small cell lung cancer (NSCLC). It can be the best replacement